We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Researchers from Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) have devised an oral insulin delivery approach that can potentially eliminate the need for daily injections for type 1 diabetics.